PT  - JOURNAL ARTICLE
AU  - Parry, Nicola
ED  - Feres, Fausto
TI  - No Change in Thrombotic Risk with Short-Term DAPT after Stenting
DP  - 2013  01
TA  - MD Conference Express
PG  - 21--21
VI  - 13
IP  - 19
4099  - http://mdc.sagepub.com/content/13/19/21.short
4100  - http://mdc.sagepub.com/content/13/19/21.full
AB  - This article presents the final results from the Optimized Duration of Clopidogrel Therapy Following Treatment With the Zotarolimus-Eluting Stent in Real-World Clinical Practice trial [OPTIMIZE; Feres F et al. JAMA 2013], demonstrating that in patients with coronary heart disease who received a drug-eluting stent (DES), cessation of dual antiplatelet therapy 3 or 12 months after implantation did not increase their risk of the composite endpoint of death, myocardial infarction, stroke or major bleeding, or stent thrombosis at 1-year follow-up.